CDMRP Lung Cancer Research Program Investigator -Initiated Translational Research Award

The Investigator-Initiated Translational Research Award (IITRA) supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. 
Partnerships with investigators at Military Treatment Facilities is strongly encouraged.

Applications must address at least one of the 10 Areas of Emphasis listed below.

• Identify innovative strategies for prevention of the occurrence of lung cancer.
• Identify innovative strategies for the screening and early detection of lung cancer.
• Understand the molecular mechanisms of initiation and progression to lung cancer.
• Understand contributors to lung cancer development other than tobacco.
• Identify innovative strategies for the treatment of lung cancer.
• Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
• Develop or optimize biomarkers to assist with therapeutic decision-making.
• Understand mechanisms of resistance to treatment (primary and secondary).
• Identify innovative strategies for comprehensive lung cancer care (clinical management/ surveillance/symptom management/palliative care).
• Understand factors and/or develop implementation strategies to address health disparities in lung cancer.

It is expected that 4 awards will be granted this year. 

Funding: $600,000
Duration: 3 years

Research Authority due date: 26.4.22

Pre application (required) due date: 4.5.22
Full application due date: 22.7.22